Stabilization of the autoproteolysis of TNF-alpha converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies - PubMed (original) (raw)
Stabilization of the autoproteolysis of TNF-alpha converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies
Richard N Ingram et al. Protein Eng Des Sel. 2006 Apr.
Abstract
The crystallization of TNF-alpha converting enzyme (TACE) has been useful in understanding the structure-activity relationships of new chemical entities. However, the propensity of TACE to undergo autoproteolysis has made enzyme handling difficult and impeded the identification of inhibitor soakable crystal forms. The autoproteolysis of TACE was found to be specific (Y352-V353) and occurred within a flexible loop that is in close proximity to the P-side of the active site. The rate of autoproteolysis was found to be proportional to the concentration of TACE, suggesting a bimolecular reaction mechanism. A limited specificity study of the S(1)' subsite was conducted using surrogate peptides and suggested substitutions that would stabilize the proteolysis of the loop at positions Y352-V353. Two mutant proteases (V353G and V353S) were generated and proved to be highly resistant to autoproteolysis. The kinetics of the more resistant mutant (V353G) and wild-type TACE were compared and demonstrated virtually identical IC(50) values for a panel of competitive inhibitors. However, the k(cat)/K(m) of the mutant for a larger substrate (P6 - P(6)') was approximately 5-fold lower than that for the wild-type enzyme. Comparison of the complexed wild-type and mutant structures indicated a subtle shift in a peripheral P-side loop (comprising the mutation site) that may be involved in substrate binding/turnover and might explain the mild kinetic difference. The characterization of this stabilized form of TACE has yielded an enzyme with similar native kinetic properties and identified a novel crystal form that is suitable for inhibitor soaking and structure determination.
Similar articles
- The P2/P2' sites affect the substrate cleavage of TNF-α converting enzyme (TACE).
Liu S, Liu S, Wang Y, Liao Z. Liu S, et al. Mol Immunol. 2014 Nov;62(1):122-8. doi: 10.1016/j.molimm.2014.05.017. Epub 2014 Jun 28. Mol Immunol. 2014. PMID: 24980871 - Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
Wu D, Gu Q, Zhao N, Xia F, Li Z. Wu D, et al. J Drug Target. 2015 Dec;23(10):936-42. doi: 10.3109/1061186X.2015.1043916. Epub 2015 Jun 10. J Drug Target. 2015. PMID: 26061299 - Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
Wisniewska M, Goettig P, Maskos K, Belouski E, Winters D, Hecht R, Black R, Bode W. Wisniewska M, et al. J Mol Biol. 2008 Sep 19;381(5):1307-19. doi: 10.1016/j.jmb.2008.06.088. Epub 2008 Jul 7. J Mol Biol. 2008. PMID: 18638486 - Novel methods and strategies in the discovery of TACE inhibitors.
Murumkar PR, Giridhar R, Yadav MR. Murumkar PR, et al. Expert Opin Drug Discov. 2013 Feb;8(2):157-81. doi: 10.1517/17460441.2013.744745. Epub 2012 Dec 12. Expert Opin Drug Discov. 2013. PMID: 23231541 Review. - Novel TACE inhibitors in drug discovery: a review of patented compounds.
Murumkar PR, DasGupta S, Chandani SR, Giridhar R, Yadav MR. Murumkar PR, et al. Expert Opin Ther Pat. 2010 Jan;20(1):31-57. doi: 10.1517/13543770903465157. Expert Opin Ther Pat. 2010. PMID: 20021284 Review.
Cited by
- S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review.
Nejat R, Torshizi MF, Najafi DJ. Nejat R, et al. Vaccines (Basel). 2023 Jan 17;11(2):204. doi: 10.3390/vaccines11020204. Vaccines (Basel). 2023. PMID: 36851081 Free PMC article. Review. - In Silico and Experimental ADAM17 Kinetic Modeling as Basis for Future Screening System for Modulators.
Bienstein M, Minond D, Schwaneberg U, Davari MD, Yildiz D. Bienstein M, et al. Int J Mol Sci. 2022 Jan 25;23(3):1368. doi: 10.3390/ijms23031368. Int J Mol Sci. 2022. PMID: 35163294 Free PMC article. - Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.
Sanna V, Satta S, Hsiai T, Sechi M. Sanna V, et al. Eur J Med Chem. 2022 Mar 5;231:114121. doi: 10.1016/j.ejmech.2022.114121. Epub 2022 Jan 13. Eur J Med Chem. 2022. PMID: 35114539 Free PMC article. - Vitamin D3 Prevents the Deleterious Effects of Testicular Torsion on Testis by Targeting miRNA-145 and ADAM17: In Silico and In Vivo Study.
Mohamed DI, Abou-Bakr DA, Ezzat SF, El-Kareem HFA, Nahas HHA, Saad HA, Mehana AE, Saied EM. Mohamed DI, et al. Pharmaceuticals (Basel). 2021 Nov 25;14(12):1222. doi: 10.3390/ph14121222. Pharmaceuticals (Basel). 2021. PMID: 34959623 Free PMC article. - ADAM17 is an essential attachment factor for classical swine fever virus.
Yuan F, Li D, Li C, Zhang Y, Song H, Li S, Deng H, Gao GF, Zheng A. Yuan F, et al. PLoS Pathog. 2021 Mar 8;17(3):e1009393. doi: 10.1371/journal.ppat.1009393. eCollection 2021 Mar. PLoS Pathog. 2021. PMID: 33684175 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous